To evaluate the potential of advanced platelet-rich fibrin (A-PRF) as a regenerative biomaterial for bone regeneration and postoperative sequelae after impacted third molar extractions. Materials and methods: This was a split-mouth, randomized, double-blind clinical trial. A total of 10 female patients in King Abdulaziz University Dental Hospital with bilateral impacted third molars were recruited into the study. Surgical extractions were performed on both sides of the mandible. Randomization was done by a coin toss; A-PRF was placed on the one side while the other side did not receive any intervention. Each patient acted as their own control. Both the patients and the investigators were blinded about the A-PRF side. The outcome on periodontal regeneration was made measuring pocket depth (PD), gum recession (GR), and clinical attachment level (CAL) before and at 1-and 3-months postoperatively. Pain, swelling, and healing were assessed on the 7th postoperative day. p value less than 0.05 was considered statistically significant.
IntroductIon
Extraction of impacted third molars is one of the most common procedures that has routinely been performed in a typical dental practice. However, this procedure has been associated with several postoperative complications such as pain, swelling, bleeding, trismus, nerve injury, and dry socket. 1 In addition, alveolar defect distal to the second molar and general oral dysfunction are common sequela after surgical removal of an impacted third molar. 2 Because surgical extraction of third molars often requires marked bone removal to expose the tooth, which may potentially jeopardize the alveolar ridge and periodontal health distal to second molars, preservation of the alveolar ridge is a mandatory step after the surgery. Hence, various bone substitutes (e.g. autograft, alloplast, and allograft) and biologics (e.g. growth factors, platelet-rich plasma) have been used to counter this side effect. 3 Platelet-rich fibrin (PRF) is a second-generation autologous platelet concentration that is obtained from the patient's own blood in a simple and cost-effective manner. 4 It has been developed as a cheaper but more biocompatible and effective alternative over the previously introduced platelet-rich plasma (PRP) for bone and soft tissue regeneration. Compared to PRP, PRF is less soluble after application, requires minimal handling of biochemical blood, and provides a more sustained release of platelet cytokines and growth factors. 5 PRF has been shown to release a number of key growth factors, including transforming growth factor β-1 (TGF β-1), platelet-derived growth factor AB (PDGF-AB), and vascular endothelial growth factor (VEGF). It also releases a homotrimeric, multifunctional glycoprotein (thrombospondin-1, TSP-1), and several pro-inflammatory cytokines such as tumor necrosis factor-α (TNF-α), interleukin 6 (IL-6), and interleukin-1 β (IL-1β). 6 Recently, Choukroun developed a modified form of PRF, known as A-PRF. 7 A-PRF clot is softer compared to PRF and contains a relatively higher number of autologous cells such as neutrophils and macrophages. 8 A recent in vitro study by Kobayashi et al. showed 1 that A-PRF releases a significantly greater number of growth factors than PRF. 9 More recently, in a randomized trial, Clark et al. demonstrated A-PRF as a potential biomaterial for alveolar ridge preservation. 10 Hence, this new formulation has been thought to be a more potent biomaterial for bone and soft tissue regeneration than the traditional PRF. However, evidence in support of the A-PRF's effectiveness in periodontal wound healing is still limited, and there is a need for standardized randomized controlled clinical trials to assess the effect of A-PRF following surgical extraction of third molars. Therefore, the aim of the present study is to evaluate the effect of A-PRF on wound healing characteristics of the third molar socket after extraction and patient comfort.
MAterIAls A n d Methods

Study Design
This was a split-mouth, randomized, double-blind clinical trial. The ethical approval for this study (Proposal ID 085-10-17) was obtained from the institutional ethics committee at the Faculty of Dentistry, King Abdulaziz University in Jeddah, Kingdom of Saudi Arabia. The study was conducted and reported in accordance with guidelines published by the CONSORT group and the World Medical Association's Helsinki Declaration of 1975, as revised in 2013. This study is registered at ClinicalTrials.gov with clinical trial registration number NCT03703479.
The study was conducted in King Abdulaziz University Dental Hospital, and the sample size calculation was done based on previous similar studies done by Uyanik et al. and Yelamali et al. 11 , 12 40 patients were screened, and after preoperative and radiographic evaluation, 10 female patients with a mirror-imaged vertical or mesioangular bilateral impacted mandibular third molars were included in the study ( Fig. 1 ). Written informed consent was obtained from each patient before recruitment. All recruited patients acted as their own control. Inclusion criteria included: (1) healthy patients with no systemic diseases, (2) age ≥18 years, and (3) non-smoker. Exclusion criteria were as follows: (1) missing second molars; (2) decayed second molar that is indicated for extraction (un-restorable and remaining roots); (3) patients under immunosuppressant or with acute infection; (4) inability or failure to attend follow-up appointments.
Surgical Procedure
All patients underwent bilateral extraction of impacted lower third molars, which were of the same level of removal difficulty. The teeth were surgically removed in a single appointment. Two sites in the second molar were selected as experimental units: (1) distobuccal (DB) site and (2) distolingual (DL) site. These two sites were chosen owing to their close proximity to the extracted tooth. Each one of the extraction sites received the biomaterial (A-PRF) while the other acted as a control. A coin toss was performed by an intern to randomly choose which side would receive the A-PRF. Both the patients and the investigators were blinded about the A-PRF side.
A maxillofacial surgeon carried out all surgical procedures following a standard operating technique. Strict aseptic precautions were undertaken prior to and during the surgery. For local anesthesia, an inferior alveolar nerve block was used, and the long buccal infiltration was administered using scandonest 2% containing 1:200,000 epinephrine. Envelope flap with distal extension was performed. A full-thickness mucoperiosteal flap was raised, and the tooth was extracted using elevators. The socket was then thoroughly irrigated with sterile 0.9% saline. To obtain A-PRF, 2 tubes (10 mL each) of venous blood was drawn. The tubes used were sterile vacuum plain tubes for A-PRF™ + and did not contain any additive or anticoagulant. They were then placed in the centrifugation machine (DUO from the PROCESS FOR PRF Company) ( Fig. 2 ) for 13 minutes at 1300 rpm. The end products (A-PRFs) were then placed in the PRF Box® to preserve the membrane and provide constant thickness ( Fig. 3 ). After the A-PRF was placed in the socket ( Fig. 4 ), primary closure of both extraction cavities was performed using 3.0 chromic gut sutures ( Fig. 5) .
Postoperatively, all patients were treated with an oral antibiotic (amoxicillin 500 mg, 8 hourly for 3 days) and a non-steroidal antiinflammatory medication (ibuprofen 600 mg, 8 hourly for 2 days). Postoperative oral hygiene instructions were also given to all patients, and a mouthwash (0.12% chlorhexidine thrice daily) was prescribed for 7 days. Sutures were removed on the 7th day.
Outcome Assessment
Outcomes were assessed using several measures, including pocket depth (PD), clinical attachment level (CAL), gum recession (GR), and visual scoring of pain, swelling, and healing. PD, GR, and CAL distal to the mandibular second molar were measured at BD and DL sites by a single examiner. Three time points were used to assess them: (t1) pre-surgery, (t2) 1-month post extraction, and (t3) three months' post extraction. A periodontal probe was used to measure the PD. GR was expressed using negative values to indicate whether the gum tissue recessed from its original position. A high negative Table 1) . Patients were asked about the level of pain experienced using a visual analog scale (VAS). Visual scores on facial swelling and healing progress were based on clinical observation.
Data Analysis
Statistical analysis was performed using R Studio software (version 3.4, RStudio Inc., Boston, MA, USA). Continuous variables such as PD, GR, and CAL outcomes were expressed as mean (x -) ± standard deviation (SD). Categorical data such as visual scores of swelling and healing were summarized as counts and percentages. VAS score was expressed using median/IQR. The difference in confidence interval was also calculated for VAS. A mixed ANOVA was used to assess the association between the intervention (vs control) and the outcome of interest at various time points. Site, time, and treatment were included as fixed effects, while subjects were treated as random variables considering the split-mouth design used. The significance of the fixed effects (p values) was assessed using the Kenwood-Roger (KR) approximation. Pain, swelling, and healing scores were compared using paired Wilcoxon signed-rank test. Pairwise t tests with Tukey's HSD correction was performed as a post hoc test. Two-tailed hypothesis testing was performed using a significance level of 0.05.
results
An estimated 10 female patients were included in the study. The mean age of these participants was 24 years. Each patient acted as their own control. Teeth were removed from both the left and right side of the mandible, and two sites, DB and DL, were chosen from each tooth for comparison. Preoperative mean values of PD, GR, and CAL in the A-PRF and control groups were comparable. There was also no statistical difference between the sites of two groups ( Table 2) . A statistically significant decrease in PD was observed in both groups at 1-and 3-months postoperatively compared to preoperative baseline ( Table 3 ). The mean value of PD was slightly lower in the A-PRF group (p = 0.002) than control (p = 0.014) at 1-month post-surgery. No significant difference was found between the 1-and 3-months postoperative PD values for both groups. Similar results were obtained when the analysis was performed separately for DB and DL sites ( Table 2 ). The mixed ANOVA analysis revealed that the decrease in PD was significantly associated with time (p < 0.001), but not with the site or treatment group (Table 4) .
GR decreased significantly in the intervention (p < 0.001) and control (p = 0.01) groups at 1-month post-surgery than preoperative baseline (Table 3 ). There was a statistically significant difference between the 1-and 3-months postoperative GR values in both groups. The mean decrease in GR at 1-and 3-months postoperatively was more evident in the A-PRF-treated DB sites Table 2 ). The mixed ANOVA analysis indicated that there was a statistically significant interaction between time and site (F = 7.35, p < 0.001), which confirmed that the patterns observed in the DB and DL sites are indeed different (Table 4 ). Pairwise comparison of pre-and post-operative values showed no statistically significant change in CAL in either of the two groups at any time point (Table 3) . Sitewise comparison revealed an increase in mean CAL at 1-month postoperatively in the A-PRF-treated DB sites (3.1 ± 1.37 mm) than control (2.1 ± 1.19 mm). At the DL sites, a decrease in mean CAL was observed in both groups at 1-and 3-months postoperatively compared to pre-surgery baseline ( Table 2 ). These differences across sites at various time points were confirmed in the mixed ANOVA analysis (Table 4) , which found a statistically significant association between site and time (F = 5.14, p = 0.008). Comparison of visual scores showed that pain (p = 0.01) and swelling (p = 0.04) on the 7th postoperative day were significantly lower in the A-PRF group compared to the control group (Table 5) . No statistically significant difference was found in healing scores between both groups.
dIscussIon
Wound healing after extraction of impacted third molars is a complex process that involves a highly coordinated interaction of cellular, molecular, biochemical, and physiological mechanisms. Various therapeutic measures have been taken to minimize postoperative complications and preserve the distal root of the second molar. 13 The application of PRF after surgical extraction of impacted third molars has been shown to be a valid approach to accelerate wound healing and minimize postoperative complications. 5 In comparison to PRP, patients treated with PRF have demonstrated a significant reduction in PD and superior healing of soft tissue. 12 , 14 Moreover, a majority of systematic reviews, animal experiments, and clinical trials published to date suggested PRF as an effective biomaterial to accelerate bone healing, stimulate osseous and epithelial tissue regeneration, and reduce postoperative pain, swelling, and trismus. 5 , 15 -18 However, contrary results have also been reported. 19 -22 The objective of this study was to test the potential of A-PRF, an advanced form of PRF, as a regenerative biomaterial to enhance bone regeneration and accelerate wound healing. Although A-PRF is known to contain more growth factors and autologous cells than PRF; 9 to date, no study evaluated its effect on wound healing. In fact, so far only a small number of studies has been conducted to determine the true clinical significance of A-PRF. This study is the first randomized controlled trial that evaluates the effectiveness of A-PRF as a potential biomaterial for socket healing of the third molar.
In the present study, PD recorded postoperatively at 1 and 3 months showed a statistically significant reduction than baseline for both A-PRF and control groups. Although there was no significant difference between the postoperative PD values of both groups, comparison of two sites at 1-and 3-months postoperatively indicated slightly better results in the A-PRF group than in the control group. These findings are comparable with the results of other PRP and PRF studies in the literature. 21 , 23 -25 However, some studies have reported more improved results compared to our findings. Sammartino et al. reported a statistically significant reduction in PD at 12 weeks in the PRP group compared to the controls. 26 Similar findings were again reported in another study by Sammartino et al. although the comparison made in this study was between PRP alone and PRP with a resorbable collagen membrane. 27 Some studies have also reported a faster decrease of PD for the case group compared to the non-treated group. Kumar et al. observed a statistically significant decrease in PD at 1 month postoperatively for the case group, but not in the control group, which indicated a faster periodontal healing in the PRF treated group than the control. 24 The effect of PRF on GR and CAL has been studied extensively in the literature. While some studies have positively supported the use of PRF for solving gingival recessions of Miller class I or II and suggested that there could be an additional gain in CAL, 23 , 28 -30 others reported no improvement in the root coverage or CAL with PRF alone or in combination with a coronally advanced flap. 31 , 32 Supporting the latter studies, a recent systematic meta-analysis of seven clinical trials by Moraschini and Barboza also suggested that in comparison to other biomaterials, PRF did not show any significant improvement in terms of root coverage, CAL, or keratinized mucosa width in the management of Miller Class I and II GRs. 33 In the present study, there were no statistically significant differences in GR and CAL between A-PRF and control groups at any time point. These findings are consistent with the reported literature that suggested no added advantage in terms of recession coverage or gain in CAL with PRF.
It has been well established in the literature that the use of PRF is a valid method to minimize postoperative pain and swelling after surgical extraction of third molars. A majority of studies published to date reported observing a statistically significant decrease in pain and swelling on the first few postoperative days in the PRF group compared to the control. 11 , 20 , 24 , 34 In addition, a recent meta-analysis by He et al. has recommended the local application of PRF into the extraction sockets for relieving pain and swelling. 5 However, some studies have also reported no significant differences in pain and swelling between the PRF and control groups. 22 , 35 , 36 In our study, pain and swelling scores recorded on the 7th postoperative day were significantly lower in the A-PRF group than the control group, which are in accordance with the findings of Kumar et al., Uyanık et al., and He et al. 5 , 11 , 24 This study had several limitations (including a small sample size, recruitment of only female subjects, and a short follow-up), which prevent generalizing the results to males. It would have been more appropriate to conduct this study with a larger sample that includes both male and female subjects. In addition, a follow-up of up to 6 months could have enabled more statistical power to detect differences in outcomes regarding the effect of A-PRF on bone regeneration.
conclusIon
The results of the present study suggest that the use of A-PRF can be a viable option for minimizing postoperative pain and swelling after surgical extraction of impacted third molars. However, A-PRF did not provide any added advantage in terms of probing depth reduction, recession coverage, and clinical attachment level gain compared to natural healing. Although the comparison of data at various time points slightly favored A-PRF over the non-treated control with respect to bone regeneration, the clinical relevance was non-significant. To obtain more meaningful outcomes, long-term randomized control studies are warranted with a larger sample and more methodically sound assessment tools. 
